DCM Shriram Fine Chemicals Limited (NSE:DSFCL)

Market Cap	2.15B
Revenue (ttm)	3.78B -9.1%
Net Income	-52.73M
EPS	-0.61
Shares Out	86.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.40 (1.62%)
Ex-Dividend Date	Jul 1, 2026

Volume	36,984
Open	25.15
Previous Close	24.85
Day's Range	23.68 - 25.40
52-Week Range	17.28 - 52.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About NSE:DSFCL

DCM Shriram Fine Chemicals Limited engages in the manufacturing and selling of chemical products and intermediates in India and internationally. Its Pharma products include D (-) alpha phenyl glycine base, D (-) alpha phenyl glycine ethyl potassium dane salt, D (-) alpha phenyl glycine chloride hydrochloride, D (-) para hydroxy phenyl glycine base, D (-) para hydroxy phenyl glycine methyl potassium dane salt, D (-) para hydroxy phenyl glycine methyl ester, DL 2-(2-Chloro Phenyl) glycine, valine hydantoin, sodium phenoxy acetate, phenoxy acetic ...

• Industry: Chemicals and Allied Products
• Founded: 2021
• Employees: 589
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DSFCL

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error